John M. Russell

9.7k citations

65 papers · 2.5k indexed · 2 hit papers · h-index 21

Impact in

Radiation top 0.5%
- Advanced Radiotherapy Techniques
Pulmonary and Respiratory Medicine top 1%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment

Papers in

Pulmonary and Respiratory Medicine 32
- Prostate Cancer Treatment and Research 25
- Prostate Cancer Diagnosis and Treatment 7
- Renal cell carcinoma treatment 3
Cancer Research 10
- Cancer, Lipids, and Metabolism 8

Co-authors: David P. Dearnaley Matthew R. Sydes Mahesh Parmar Robert Huddart Edwin Aird J. H. Matthews John D. Graham David Bottomley
Journals: Journal of Clinical Oncology (13 papers)The Lancet Oncology (3 papers)British Journal of Urology (3 papers)European Journal of Cancer (2 papers)International Journal of Urology (2 papers)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

John M. Russell

62 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial 2014 · 344 citations

Peers

Countries citing papers authored by John M. Russell

Since Specialization

Citations

This map shows the geographic impact of John M. Russell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Russell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Russell more than expected).

Fields of papers citing papers by John M. Russell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Russell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Russell. The network helps show where John M. Russell may publish in the future.

Co-authors

The 25 scholars most cited alongside John M. Russell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John M. Russell Line = papers co-authored together John M. Russell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Finerenone in Type 1 Diabetes and Chronic Kidney Disease New England Journal of Medicine ·Hiddo J.L. Heerspink, Andreas L. Birkenfeld, David Z.I. Cherney, Helen M Colhoun, Per-Henrik Groop, Linong Ji, Niels Jongs, Chantal Mathieu, Richard E. Pratley, Sylvia Rosas, Peter Rossing, Jay S. Skyler, Katherine R. Tuttle, Robert Lawatscheck, Meike Brinker, Markus F. Scheerer, John M. Russell, Patrick Schloemer, Janet B. McGill	2026	0
2	Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations Nephrology Dialysis Transplantation ·Hiddo J.L. Heerspink, Rajiv Agarwal, Antonio J. Amor, Jesper Nørgaard Bech, David Z.I. Cherney, Paolo Fiorina, Peter Rossing, Karoline Schousboe, Nicholas M. Selby, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luís M. Ruilope, Robert Lawatscheck, Meike Brinker, John M. Russell, Patrick Schloemer, Janet B. McGill	2025	1
3	Transdermal oestradiol (tE2) patches as androgen deprivation therapy (ADT): Efficacy and safety of combining with androgen receptor pathway inhibitors (ARPIs) in metastatic (M1) prostate cancer—Randomised comparison from the STAMPEDE trial platform. Journal of Clinical Oncology ·Nicholas D. James, Hannah Rush, Matthew Nankivell, Jyoti Sehjal, Stephen Mangar, Neil McPhail, Simon J. Brown, Jacob Tanguay, Joanna Gale, Wael Mohamed, Simon J. Crabb, Omar Khan, John M. Russell, William Cross, Claire Murphy, John Deighan, Noel W. Clarke, Mahesh Parmar, Duncan C. Gilbert, Ruth E. Langley	2025	1
4	LBA4 Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men with high-risk non-metastatic (M0) prostate cancer (PCa): Combined analysis from two comparisons in the STAMPEDE platform protocol Annals of Oncology ·Gerhardt Attard, Louise Brown, Nigel Clarke, Laura Murphy, William Cross, Robert H. Jones, Silke Gillessen, John M. Russell, Adrian Cook, Julie Bowen, Anna Lydon, Ian Pedley, Omi Parikh, S. Chowdhury, Zafar Malik, David Matheson, Chris Parker, Matthew R. Sydes, Max Parmar, Nicholas D. James	2021	5
5	Transoral thyroidectomy: advantages and limitations Journal of Endocrinological Investigation ·Gianlorenzo Dionigi, Ralph P. Tufano, John M. Russell, Ho Yeon Kim, Eliana Piantanida, Angkoon Anuwong	2017	59
6	Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial The Lancet Oncology ·David P. Dearnaley, Gordana Jovic, Isabel Syndikus, Vincent Khoo, Richard Cowan, John D. Graham, Edwin Aird, David Bottomley, Robert Huddart, Chakiath Jose, J. H. Matthews, Jeremy Millar, Claire Murphy, John M. Russell, Christopher Scrase, Mahesh Parmar, Matthew R. Sydes Hit paper breakdown →	2014	344
7	Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019) European Urology ·Nicholas D. James, Melissa Spears, Noel W. Clarke, David P. Dearnaley, Johann S. de Bono, Joanna Gale, John Hetherington, Peter Hoskin, Robert J. Jones, Robert Laing, J.F. Lester, Duncan B. McLaren, Christopher Parker, Mahesh Parmar, A.W.S. Ritchie, John M. Russell, Räto T. Strebel, George N. Thalmann, Malcolm D. Mason, Matthew R. Sydes	2014	281
8	Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial Trials ·Matthew R. Sydes, Mahesh Parmar, Malcolm D. Mason, Noel W. Clarke, Claire Amos, John Anderson, Johann S. de Bono, David P. Dearnaley, John Dwyer, Charlene Green, Gordana Jovic, A.W.S. Ritchie, John M. Russell, Karen Sanders, George N. Thalmann, Nicholas D. James	2012	100
9	Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial The Lancet Oncology ·Nicholas D. James, Matthew R. Sydes, Malcolm D. Mason, Noel W. Clarke, John Anderson, David P. Dearnaley, John Dwyer, Gordana Jovic, A.W.S. Ritchie, John M. Russell, Karen Sanders, George N. Thalmann, Gianfilippo Bertelli, Alison Birtle, Joe M. O’Sullivan, Andrew Protheroe, Denise Sheehan, Narayanan Srihari, Mahesh Parmar	2012	68
10	A Randomised Double-blind Placebo-controlled Trial to Determine the Effect of Cranberry Juice on Decreasing the Incidence of Urinary Symptoms and Urinary Tract Infections in Patients Undergoing Radiotherapy for Cancer of the Bladder or Cervix Clinical Oncology ·Cordelia Cowan, C. Hutchison, Thom Cole, Sarah Barry, James Paul, Nicholas S. Reed, John M. Russell	2011	37
11	Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial The Lancet Oncology ·David P. Dearnaley, Matthew R. Sydes, John D. Graham, Edwin Aird, David Bottomley, Richard Cowan, Robert Huddart, Chakiath Jose, J. H. Matthews, Jeremy Millar, Andrea Moore, Rachel C. Morgan, John M. Russell, Christopher Scrase, Richard Stephens, Isabel Syndikus, Mahesh Parmar Hit paper breakdown →	2007	686
12	Metachronous metastasis to the penis from carcinoma of the rectum International Journal of Urology ·Sree Appu, Nathan Lawrentschuk, John M. Russell, N Bright	2006	17
13	The development of prostate cancer despite late onset androgen deficiency International Journal of Urology ·Shomik Sengupta, H. J. Duncan, R. J. MacGregor, John M. Russell	2005	6
14	Ureteric stenting 25 years on: routine or risky? ANZ Journal of Surgery ·Nathan Lawrentschuk, John M. Russell	2004	39
15	Identification and Immunohistochemical Characterization of a Mucin-Like Glycoprotein Expressed in Early Stage Breast Carcinoma Tumor Biology ·Tracey Colpitts, P Billing, Edward N. Granados, Mark Hayden, Steve Hodges, Lisa Roberts, John M. Russell, Paula N. Friedman, Steve Stroupe	2002	21
16	The Royal College of Radiologists' Clinical Oncology Information Network. British Association of Urological Surgeons. Guidelines on the management of prostate cancer. PubMed ·Mason ', Peter R. Malone, Noel W. Clarke, D. Kirk, Leslie Moffat, Christopher R. Chapple, David E. Neal, D.P. Dearnaley, Natalie James, CJ Tyrrell, John M. Russell, Bernadette M. Carrington, C. Gallagher, Amanda Baxter, Ani S Movsisyan Vernon, Jill Hardy, S.J. Karp, A Goldie, carol duncan	1999	30
17	Antibody-induced arterial thromboembolism resulting in amputation after total knee arthroplasty The Journal of Arthroplasty ·George D. Markovich, John M. Russell, Paul J. Gagne	1997	3
18	A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer Radiotherapy and Oncology ·P.M. Quilty, D. Kirk, J.J. Bolger, David P. Dearnaley, Valerie Lewington, M. Masone, Nicholas Reed, John M. Russell, J. H. Yardley	1994	230
19	Type IV flexor digitorum profundus avulsion The Journal Of Hand Surgery ·W. Andrew Eglseder, John M. Russell	1990	24
20	Seven exercises planned to stimulate the flow of ideas in creative composition OpenBU (Boston University) ·Richard Conley, Geneviève A. Courant, Mortimer J. Downey, Edna F. Greenbaum, Elsie C. Halonen, Donna D. Renda, John M. Russell	1955	0

About John M. Russell

John M. Russell is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Obstetrics and Gynecology, Urology and Radiology, Nuclear Medicine and Imaging, having authored 65 papers that have together received 2.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (25 papers), Cancer, Lipids, and Metabolism (8 papers), Prostate Cancer Diagnosis and Treatment (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Cancer Treatment and Pharmacology (4 papers), Ureteral procedures and complications (4 papers), Pediatric Urology and Nephrology Studies (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Radiation (708 citations), Pulmonary and Respiratory Medicine (1.8k citations), Radiology, Nuclear Medicine and Imaging (485 citations), Urology (132 citations) and Oncology (410 citations). John M. Russell has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include David P. Dearnaley, Matthew R. Sydes, Mahesh Parmar, Robert Huddart, Edwin Aird, J. H. Matthews, John D. Graham, David Bottomley, Isabel Syndikus and Chakiath Jose. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology, British Journal of Urology, European Journal of Cancer and International Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact